VASN promotes the aggressive phenotype in ARID1A-deficient lung adenocarcinoma. Wu DN, Zhang KL, Chen RH, Ye WS, et al. BMC Cancer 2024;24:1327.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu DN, Zhang KL, Chen RH, Ye WS, et al. VASN promotes the aggressive phenotype in ARID1A-deficient lung adenocarcinoma. BMC Cancer 2024;24:1327.
PMID: 39472811